Company Overview

Development Stage

About the Company

深圳市贝美药业有限公司(简称“贝美药业”),国家高新技术企业、深圳市专精特新企业。贝美药业专注于儿童处方药领域,集“研发、生产、销售、全球合作”全产业链能力于一体,以优秀儿科产品的自主研发及全球合作引进作为重点驱动战略,依托贝美药业连云港生产基地,满足多种儿童特殊药物剂型的生产和全球供应,旨在为儿童患者提供高品质、全系列的药品。贝美药业已布局40余款儿童产品,已获批上市产品4个,其中多个创新药产品拥有全球权益和自主知识产权,目前产品管线覆盖了皮肤科、呼吸系统、消化系统、抗感染、神经系统、新生儿、遗传内分泌系统等领域。贝美药业于2024年5月15日完成了对TWYNEO®在中国(含香港、澳门、台湾)及以色列的资产收购,加强了其在皮肤科领域的布局。TWYNEO®是FDA批准的*个也是*一个由维A酸和过氧化苯甲酰固定剂量组合的外用乳膏,用于治疗九岁及以上儿童和成人患者的寻常痤疮。贝美药业与多家全球国际大型制药公司建立了长期合作伙伴关系,例如Hetero、Cipla、Deva、Dr. Reddy’s、LTS、MedPharma、Synthon、EMP、NTC、Syrimed、Sol-Gel等公司。贝美药业已完成天使轮,A轮,B/B+ 轮以及C轮数亿元融资,获得倚锋资本及产业方在内的多家知名投资机构认可。

Expand
Information is aggregated from the web and may not be exact. For reference only.
Information incorrect? Claim this company to edit

贝美药业 Financing History (2 rounds)

Manage
C轮
Capital Market Favor
Latest Financing Round
  • Date: ?
  • Amount: 融资金额未公开
  • Investor: 南山战新投,江苏金桥私募基...

贝美药业 How Fast Is Hiring Growing? (15 open positions)

Manage
Note: How fast is hiring at 深圳市贝美药业有限公司 growing? 贝美药业2026: 41 openings (down 69%), 2025: 134 openings (down 23%), 2024: 175 openings (up 133%), 2023: 75 openings (up 9%), 2022: 69 openings (up 188%), 2021: 24 openings. A rising curve may indicate expansion; a falling curve may indicate slower growth or good retention. Based on publicly available data, for reference only.

贝美药业 Master's Degree Job Demand Analysis

(More)
?
Growth Rate
2026 vs 2025
  • 2025: Down 13%
  • 2024: Up 158%
  • 2023: Up 33%
贝美药业 Master's Hiring by Year:
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is master's hiring at 深圳市贝美药业有限公司 growing? 贝美药业Master's recruitment over the years: 2025: 27 openings (down 13%), 2024: 31 openings (up 158%), 2023: 12 openings (up 33%), 2022: 9 openings.

贝美药业 Doctoral Degree Job Demand Analysis

(More)
-86%
Growth Rate
2026 vs 2025
  • 2025: Flat 0%-
  • 2024: Up 133%
  • 2023: Up 200%
贝美药业 Doctoral Hiring by Year: 2026 — 6 fewer jobs than 2025
* Hiring was generally low during 2020-2022 due to the pandemic
How fast is doctoral hiring at 深圳市贝美药业有限公司 growing? 贝美药业Doctorate recruitment over the years: 2026: 1 openings (down 86%), 2025: 7 openings (flat), 2024: 7 openings (up 133%), 2023: 3 openings (up 200%), 2022: 1 openings.

贝美药业 R&D Strength (Technical Talent Demand)

(More)
How is the demand for technical talent at 深圳市贝美药业有限公司? Based on an analysis of 贝美药业's job postings over the past year, "生物/制药/化工/环保类" demand: 21.3%, "医疗卫生/美容保健类": 19.1%, "其他(研发和技术类)": 8.5%, "机械/仪器仪表类": 4.3%, "电气/能源/动力类": 4.3%, "计算机/网络/技术类": 4.3%. For reference only.

贝美药业 — What Are the Salaries Like? (47 records)

Manage
贝美药业 Salary Overview
salary range: 6K - 50K, 72.2% of roles pay ¥10-50K
Note: salary statistics are based on 47 salary records from the past year and depend on the job sample. For reference only.
How is the salary at 深圳市贝美药业有限公司?贝美药业72.2% of positions earn 10-50K, Undergraduate salary: ¥。销售类 average salary ¥23.6K。 Note: Based on analysis of job postings, does not represent current on-the-job positions; system stability may affect objectivity. For reference only.Data inaccurate? Let us know

Salaries for hot jobs of 贝美药业

(More)
Are salaries high at 深圳市贝美药业有限公司? We provide: 推广,质量,临床,仓储,供应链,分析,制剂研发,制剂经理,医学经理,商务经理,工艺工程,市场,技术经理,电气,设备工,运营,采购,bd,ma,qa. Click to view detailed salary analysis by job.

贝美药业 honors, qualifications & industry associations

贝美药业 Related Industry Tags

Job Category

  • 销售类
    29.8% of total 29.8%
  • 经营管理类
    23.4% of total 23.4%
  • 生物/制药/化工/环保类
    21.3% of total 21.3%
  • 医疗卫生/美容保健类
    19.1% of total 19.1%

Education

  • 本科
    46.8% of total 46.8%
  • 硕士
    25.5% of total 25.5%
  • 大专
    19.1% of total 19.1%
  • 高中
    6.4% of total 6.4%

Experience

  • 3-5年
    40.4% of total 40.4%
  • 5-10年
    29.8% of total 29.8%
  • 1-3年
    25.5% of total 25.5%
  • 不限
    4.3% of total 4.3%
View Detailed Analysis

What does 深圳市贝美药业有限公司 require? Who is 贝美药业 hiring? 贝美药业 recruitment: 销售类占比最多占29.8%,其次是经营管理类占23.4%. What education can get in at 贝美药业? 本科占比最多占46.8%,其次是硕士占25.5%. High education required at 贝美药业? 硕士占25.5%,博士占2.1%. Work experience required at 贝美药业? 3-5年占比最多占40.4%,其次是5-10年占29.8%. Where are the job locations at 贝美药业? 深圳占比最多占80.9%,其次是连云港占19.1%. Based on job postings from the past year, for reference only.

Business Registration

Provided by

Operating Status: 开业
Registered Capital: 1,490.4883万(元)
Legal Representative: 吴光美
Date Established:
Credit Code: 91440300760624748T
Registered Address: 深圳市南山区粤海街道科技园社区科苑路15号科兴科学园A栋A1-1501、1502、1503、1505

Partners & Suppliers

与贝美药业合作开发儿童药物制剂 Source
供应商 药品研发
贝美药业通过九州通医药集团分销其儿童药品 Source
合作客户 医药商业

People who follow 贝美药业 also follow

贝美药业 Competitors (Similar Companies)

“Research, development, and production of anti-tumor and surgical medic”
“One of the leading enterprises in the pharmaceutical industry”
医药 药物研发 生物制药 制药/药业
“A renowned enterprise in China's liver disease and anti-tumor fields”
制药/药业 药物研发 生物制药 医药
制药/药业 医药 生产 医药分析
“Dedicated to the research and development of molecularly targeted drug”
“无机填料和颗粒载体”
制药/药业 医药 中成药 青霉素
制药/药业 医药 原料药 化学原料药
“A strong private pharmaceutical group”
医疗器械 生产 医疗耗材 健康产业
制药/药业 抗生素 原料药 化学原料药
健康管理 大健康 口腔医疗 老年病
“Committed to building a humanistic Daxiang and a century-old Daxiang”

Report

*Reason:

Radical political or ideological topics
Advertising or spam
Pornographic or vulgar content
Obscene language or personal attacks
Other

Congratulations, submitted successfully!

Your edit is under review. You will be notified by email within 1 business day.

Submission failed.

Followed successfully. We'll notify you of any company updates.

Help others learn about this company, add my impression of this company»

Log in with the following accounts to save your follows

Followed successfully, we'll notify you of any company updates